2017 Board of Directors Election

All members of the Metabolomics Society are welcomed and encouraged to participate in the 2017 Board of Directors election. Voting is open now through August 31, 2017 at 11:59pm USA CST. Complete details on elections can be found here.

This webpage contains a list of nominees as well as biographies and statements of interest regarding serving on the Board. Please take a moment to review this information before placing your votes.

List of Nominees:

Standing for a second term:

New Nominees:

How to Vote:

Each member has two (2) votes. You will need to enter your member email address to begin voting.
An e-mail was sent August 10, 2017 to all members containing the email address. If you cannot find your member email address, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. for assistance.

vote here btn


Sastia Prama Putri (Standing for a second term)

Osaka University (Japan)

Biography: Sastia Prama Putri is an Assistant Professor at the Graduate School of Engineering, Osaka University and an adjunct lecturer at the School of Life Sciences and Technology, Institut Teknologi Bandung. She received her PhD from the International Center for Biotechnology, Osaka University in which she worked on the discovery of novel bioactive compounds from natural products. Her current research includes the application of metabolomics technology for optimizing biofuel production and food metabolomics studies focusing on food authentication and quality evaluation. She is the first Chair of the Early members Network of the Metabolomics Society and is a current member of the board of director of the international Metabolomics Society. She won the L’Oreal Award for Women in Science in 2015 for her work on coffee metabolomics and is actively promoting metabolomics research in her home country, Indonesia.

Statement of Purpose: If re-elected as a Director, i would focus on strengthening the network between the Society and its affiliates as well as our industry partners.

I would dedicate effort to promote metabolomics research in countries that are starting up metabolomics research, particularly in the Asian region, by organizing regional workshops to expand the network and increase membership. As the first Chair of the Early career Members Network of the Metabolomics Society, I and fellow members of the EMN launched the EMN webinar series and placed a structure for the operation of the EMN. As a director, I will encourage more training activities and workshops, especially to form new collaborations as well as application area in metabolomics.

Back to top

Dong-Hyun Kim

University of Nottingham (UK)

Biography: Dr Dong-Hyun Kim was appointed as an Assistant Professor/Lecturer in Analytical Bioscience in the School of Pharmacy, the University of Nottingham in October 2013. The School of Pharmacy is ranked 6th in the world for Pharmacy and Pharmacology (QS World Rankings, 2017) and top for research quality and impact (100% 4*) for Schools of Pharmacy in the UK (REF2014). Prior to this position he conducted postdoctoral research on the development of MS-based metabolite profiling for clinical metabolomics of trypanosomes in Glasgow Biomedical Research Centre at the University Glasgow (2010-2013) after four years in the School of Chemistry at the University of Manchester obtaining his PhD (2006-2010) under the supervision of Prof. Roy Goodacre, which involved the development and application of analytical instruments for the investigation of cervical cancer. His research career has focused on the advancement and application of mass spectrometry (MS)-based methods in order to investigate complex samples and matrices in life sciences and physical sciences, and has a strong track record in fostering collaborative science where novel analytical approaches can make significant impacts on new areas of investigation. Dr Kim is also a co-leader of the Centre for Analytical Bioscience and he oversees and manages the mass spectrometry facility. Dr Kim’s role includes coordination of internal and external project work as well as fostering interdisciplinary applications of mass spectrometry-based analytical techniques. He has recently joined Metabolic Profiling Forum as a director and has co-organised the Metabomeeting conferences.

Statement of Purpose: I think this is a great opportunity to work with the Metabolomics Society to contribute to growing the exciting metabolomics fields more rapidly. Through serving as a director of the Board, I would like to make a substantial contribution to widen the current bottleneck resulting from difficulties of integrating ‘omics’ data, international standardisation and data sharing. I would also like to make good progress on bridging metabolomics and wider scientific and research communities to fill the gaps for human health, disease and wellbeing for life by sharing successful applications of advanced metabolomics methods. Lastly, I wish to promote education for junior members of the metabolomics community regarding design of experiments, rigorous normalisation of metabolomics data and clinical applications.

Back to top

Jessica Lasky-Su

Brigham and Women's Hospital and Harvard Medical School (USA)

Biography: Dr. Lasky-Su is an Associate Professor in Medicine at Brigham and Women’s Hospital and Harvard Medical School. She earned her doctoral degree in Genetic Epidemiology from Harvard School of Public Health in 2005. Dr. Lasky-Su has spent the last 18 years focusing on the identification of genetic, genomic, and metabolomic determinants for complex diseases, with a particular focus on asthma. The accumulation of these efforts has resulted in over 100 peer-reviewed original research manuscripts. Dr. Lasky-Su’s more recent work has focused on analytic and network approaches to integrate metabolomics and other omics data types with the end goal of making strides towards precision medicine. She is currently the principal investigator and co-investigator on several R01 grants that focus on the integration of metabolomics and other omics data types for several diseases. Through these efforts she has developed a metabolomics research program at the Channing Division of Network Medicine that is highly successful and synergistic in nature, as it has drawn together a diverse group of investigators with broad research interests. This work of this group has resulted in the identification of important metabolic pathways and genetic determinants for asthma, macular degeneration, pre-eclampsia, food allergy, and several other complex diseases. Dr. Lasky-Su has made great strides to educate the broader medical research community in metabolomics, which is reflected by development of the 2017 symposium “Metabolomics: Fast growing technology in Precision Medicine,” the Harvard Catalyst nanocourse entitled “Network Medicine: Using Metabolomics Data in Network Medicine,” and the 2017 Metabolomics Society workshop entitled “Network medicine approaches for the analysis of metabolomic data.” Dr. Lasky-Su also serves on the COMETs and the TOPMed metabolomics steering committees with the goal of promoting metabolomics and integrative omics in large population-based cohorts.

Statement of Purpose: As a director, my primary goal is to work to better the good of the metabolomics community at large. I will represent the growing community of epidemiologists who are interested in utilizing metabolomic data to study the etiology of complex diseases and work to continue to integrate this research group into the broader metabolomics community. I will work to promote the following objectives: 1) To promote the use of metabolomics among the broader epidemiological community with well characterized cohorts and clinical trial data; 2) To educate the metabolomics community on a broad spectrum of analytic and statistical approaches that can be applied to metabolomics data; 3) To foster the growing interest in the accumulation and analysis of multi-omic data in well characterized cohorts; 4) To encourage collaborative relationships that foster better science among the metabolomics community; and 5) To work to harmonize across platforms, laboratories, and populations..

Back to top

Thomas Metz

Pacific Northwest National Laboratory (USA)

Biography: Tom Metz received his Ph.D. in Chemistry from the University of South Carolina, using mass spectrometry to study the role of the Maillard reaction in the development of diabetic complications and in aging. He then conducted post-doctoral studies in separations coupled with mass spectrometry at Pacific Northwest National Laboratory (PNNL) with a major focus on metabolomics and minor focus on proteomics.

Currently, he is a staff scientist and the metabolomics technical lead in the Integrative Omics group at PNNL, as well as the Team Lead for a group of 18 scientists that focuses on applications of high throughput metabolomics, lipidomics and proteomics methods to various biological questions. His research has focused on the development of both untargeted and targeted metabolomics and lipidomics capabilities based on chromatographic and other separations coupled with mass spectrometry, for fundamental studies of metabolism and metabolic interactions, as well as for biomarker discovery in the context of both chronic and infectious disease.

Statement of Purpose: While at Pacific Northwest National Laboratory (PNNL) I have had the opportunity to be immersed in both metabolomics and proteomics technology and methods development, and to apply both of these individually and together in studies of a variety of biological systems. In doing so, I have come to appreciate the relative ease with which peptides and the associated proteins can be confidently identified with estimates of false discovery. I also am a believer in using multi-omics approaches to gain a more comprehensive understanding of biological systems.

My goals as a member of the Board of Directors of the Metabolomics Society are as follows: 1) to promote the use of multi-omics studies for a more comprehensive understanding of underlying biology and a more effective interpretation of metabolomics data, 2) to advance metabolomics measurement approaches and metabolite identification methods that lend themselves towards a more complete automation of data analysis pipelines, including robust scoring of metabolite identifications and assessments of false discovery rates, and 3) to facilitate the transfer of the advanced instrumentation and associated measurement methods developed at PNNL to the larger metabolomics community.

Back to top

Lee Roberts

University of Leeds (UK)

Biography: Dr Lee Roberts is a Diabetes UK RD Lawrence Fellow and a 250 Great Minds University Academic Fellow at the Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, UK. His research focuses on metabolism, the phenotypes and mechanisms of metabolic disease, and the role metabolites play in the homeostatic regulation of adipose tissue and skeletal muscle. Research in Dr Roberts' laboratory has a translational approach ranging from cell culture and animal models through to clinical and epidemiological studies. His research employs combined LC-MS and GC-MS based metabolomics and lipidomics techniques to study small molecule inter-organ cross-talk in the metabolic syndrome, and aims to uncover novel treatments for the twin global epidemics of type 2 diabetes mellitus and obesity.

As an undergraduate Lee studied Biochemistry at the University of Bristol before moving to the University of Cambridge to complete his PhD in metabolism and metabolomics in the laboratory of Professor Julian Griffin in the Department of Biochemistry. Following completion of his PhD he was awarded the Leducq Foundation Career Development Award to conduct postdoctoral research in the laboratory of Professor Robert Gerszten at Massachusetts General Hospital, Harvard Medical School, USA. Prior to his appointment in Leeds, Dr Roberts was the Elsie Widdowson Fellow at the Medical Research Council Human Nutrition Research Unit and a Research Fellow at Wolfson College, at the University of Cambridge, UK.

Dr Roberts' research has been published in leading international peer reviewed scientific and medical journals including Cell Metabolism, The Lancet Diabetes and Endocrinology, Genome Biology, Circulation and Diabetes.

Statement of Purpose: With over a decade of experience in the application of metabolomics across scientific and medical studies I feel I can make a significant contribution to the Metabolomics Society. My extensive experience in the application of metabolomics to mouse and rat models would contribute to the Societies Model Organism Metabolomes Task Group, whereas my experience of both small scale clinical metabolomics studies and large scale human population metabolomics studies will be beneficial to the work conducted by the Precision Medicine and Pharmacometabolomics Task Group. Moreover, I would be interested in contributing towards bridging the subjective gap between these two task groups and believe my experience across the translational divide may be of use in this endeavour.

Back to top

Horst Joachim Schirra

The University of Queensland (Australia)

Biography: Dr Schirra is one of the leaders of NMR-based metabolomics in Australia. He studied Chemistry at the Johann-Wolfgang-Goethe University in Frankfurt, Germany, and received his PhD in Biochemistry from the Swiss Federal Institute of Technology (ETH) in Zurich (Switzerland). In 1999, he joined the University of Queensland, where he was awarded a Postdoctoral Fellowship of the Australian Research Council and a prestigious Queensland Smart State Fellowship. In 2009, Dr Schirra became an independent Lecturer in the School of Chemistry and Molecular Biosciences at UQ, and in 2012 he joined UQ's Centre for Advanced Imaging, where he leads a multidisciplinary research program in Metabolic Systems Biology and administers the Centre’s newly established facility for NMR-based metabolomics.

Dr Schirra uses NMR-based metabolomics to investigate the basic principles of metabolic regulation and the role they play in fundamental biological processes, environmental change, and in the development of disease, especially obesity and cancer. His research aims to integrate metabolomics with other –omics methods and metabolic simulations.

Dr Schirra is Board Member of the Australian and New Zealand Society for Magnetic Resonance (ANZMAG) and committee member of the Australian and New Zealand Metabolomics Network (ANZMN). He has been a member of the Metabolomics Society since 2008 and was Co-chair of the 13th International Conference of the Metabolomics Society in Brisbane 2017. He is editorial board member of the journals Metabolites, and International Scholarly Research Notices, and regional editor of Current Metabolomics.

Statement of Purpose: I believe that to continue to be successful, metabolomics has to engage in interdisciplinary research with other related fields. That was the major motivation for the theme of the 2017 Metabolomics Conference being “Building bridges”, and as board member I would continue my work in this vein by developing contacts between the Metabolomics Society and researchers and societies in cognate fields, such as systems biology, metabolic modelling, and natural products chemistry. This will enrich the field by bringing in new perspectives and potential solutions for bottlenecks in the metabolomics pipeline. I am also board member of the Australian and New Zealand Society for Magnetic Resonance (ANZMAG), so there are already natural contact points between both societies.

In addition to building bridges to cognate disciplines I would also like to deepen networks between researchers in the Asia-Oceania region and be a voice for that region on the board. The first dedicated meet-up of metabolomics researchers from this region at Metabolomics 2017 was a great success, and I would like to harness the momentum gathered to enhance links within Asia-Oceania. The spectrum of potential engagement opportunities is wide and ranges from professional networks between Society affiliates in the region, regional off-cycle conferences by Society affiliates, assistance in establishing further regional society affiliates, to the potential establishment of an Asia-Oceania chapter of the Metabolomics Society.

My other passion is education, and I would like to add to the Society’s efforts in that area. In 2016, I organised a scientific visit by David Wishart to Australia and New Zealand, which included a 3-day course on NMR-based metabolomics comprising 14 lectures. These lectures were recorded and have just been made available publicly on the ANZMAG YouTube channel. I would like to facilitate similarly successful educational activities and accessible content of the Metabolomics Society.

Back to top

Fidele Tugizimana

University of Johannesburg (South Africa)

Biography:  Dr. Fidele Tugizimana – is originally from Rwanda, and currently living in South Africa (SA). After the completion of a B.Phil. degree in Philosophy (magna cum laude, Urbaniana University, Rome 2004), Fidele enrolled in a B.Sc. Biochemistry-Chemistry program at the University of Johannesburg, South Africa in 2006. In 2012, he completed an M.Sc. in Biochemistry (cum laude). His M.Sc. research involved using a multi-platform (LC-/GC-MS and NMR) metabolomic approach to elucidate molecular mechanisms involved in tobacco (N. tabacum) cells responding to ergosterol elicitation. This work resulted in four articles in leading peer-reviewed scientific journals, including PLoS ONE and Molecular Plant Pathology. Fidele then completed his PhD degree in Biochemistry (summa cum laude) at the University of Johannesburg, in 2017. His PhD work consisted of using metabolomics approaches (complemented with gene expression analyses) to elucidate the biochemistry of sorghum-fungal interactions and the protective effects of rhizobacteria. His PhD work has led to several manuscripts (some already published and others submitted in peer-reviewed scientific journals). His work has also been presented at different local and international conferences, including the last three metabolomics international conferences (San Francisco–2015, Dublin–2016 and Brisbane–2017). In addition to his M.Sc. and PhD projects, Fidele has been involved in other metabolomics research projects in the Department of Biochemistry (at UJ). Some of these projects consist of metabolite structural elucidation. Fidele has attended different workshops and courses on metabolomics/metabolism such as the EMBO metabolomics workshop (UK, 2013) and metabolic modelling and pathway analysis course (Wageningen University, Netherlands, 2014). He is also involved in metabolomics workshops in South Africa as an organizer and a trainer: e.g. SIMCA-based data analysis workshop in 2015 (with Imperial college team: Ruey Leng Loo and Kimhofer Torben), Metabolomics workshops in March 2016 and 2017 (with Drs. Reza Salek, Karl Burgess, Fabien Jourdan, Justin van Hooft and Naomi Rankin). Fidele is an active member of the International Metabolomics Society: (i) a committee member and secretary of the Early-career members Network (EMN) till end of September 2017; (ii) a member of the Society Strategy Task group; and (iii) member of the International Organizing Committee (IOC) for the Metabolomics Conference 2017. In addition to being a member of the Metabolomics Society, Fidele is also a member of SA scientific societies (such as ChromSA, SAAMS and SASBMB) and a lifetime member of the Golden Key International Honour Society (since 2007).

Statement of Purpose: If trusted and elected for a Director position on the BoD of the metabolomics society, I would like to continue serving the metabolomics society (and the metabolomics community in general) in ways that promote the growth, use and understanding of metabolomics in the life sciences across the globe, and particularly in South Africa and in Africa in general. I look forward to fostering metabolomics training workshops on different aspects of a metabolomics workflow: from experimental design to data interpretation. When elected as a Director, I will also promote collaborations between different research groups/individuals (with different expertise) from different parts of the globe.

Back to top

Vidya Velagapudi

Institute for Molecular Medicine Finland (Finland)

Biography: Vidya Velagapudi obtained her Bachelors in Bioscience (1999), Masters in Biotechnology (2001), Advanced PG diploma in Bioinformatics (2002), and then joined a Pharmaceutical company as a Research Associate, Proteomics group (2002) in India. Later on she moved to Germany in 2003 for her graduate studies and obtained Ph.D in Applied Biochemistry (Metabolic flux analysis) from the University of Saarland in collaboration with the Max-Planck Institute for Informatics, Saarbrucken. Dr. Velagapudi then moved to VTT Oy, Finland as a Post-doctoral fellow (Systems Biology) in collaboration with University of Cambridge, UK, and continued as a Research Scientist and Project Manager during 2006-2009.

In 2010, Dr. Velagapudi had taken up the role as Head of the Metabolomics Unit at Institute for Molecular Medicine Finland (FIMM). Dr. Velagapudi is also affiliated to University of Helsinki (UH) as an Adjunct Professor (2012-) and Principal Investigator at the Faculty of Medicine (2016-), and Chair of Metabolomics Technology Platforms in Biocenter Finland (national core facility) and Helsinki Institute of Life Sciences HiLIFE (2017-).

Dr. Velagapudi has published over 40 scientific articles in international journals and given over 30 invited talks in international scientific events and conferences. Dr. Velagapudi has been acting as a reviewer for international journals and also for funding applications in the field of metabolomics. Dr. Velagapudi has been teaching and organising Metabolomics workshops since 2010, and elected as a steering board member for international Master’s program in Translational Medicine at UH (2017-2020). Dr. Velagapudi was an invited Metabolomics technology expert for an interview (2014) and spotlight article contributor (2016) at MetaboNews Letter, and guest editor for Metabolites Journal (2014, 2017).

Statement of Purpose: I am currently heading the Metabolomics/Lipidomics/Fluxomics national core service facility at FIMM, University of Helsinki, Finland. I have over 10 years of experience and a strong track record in metabolomics applications in biomedicine field using systems biology strategies.

As a member, I have been already contributing to the Metabolomics Society. I served as an international organising committee member for the 13th International Conference of the Metabolomics Society, Australia (2017). In addition, I am an active member of the Society’s “Precision Medicine and Pharmacometabolomics task group”, where I have been regularly participating in the group activities since joining. Within this task group, I am also leading a subtask working group focusing on formulating “Biobanking and processing procedures for biological samples for metabolomics research”.

Based on my experience, if elected as a Director, I am willing to contribute to the following additional task groups and committees:

Conferences and Training Committee:
Organising international conferences, workshops and training is the best way to promote the metabolomics science. This offers a good opportunity for students and early-career stage researchers to learn the latest techniques and developments in the field. I have an extensive experience in teaching and organizing meetings and workshops, and we are also part of the “European Metabolomics Training Coordination Group” (www.emtrag.eu).

Data Quality Task Group:
In order to generate a high-quality metabolomics dataset, standardized protocols are needed. A collective effort should come from different metabolomics laboratories across the globe to standardize the protocols and to share the metabolite annotations. We have been actively working on promoting good quality control and quality assurance practices, and also inter-laboratory comparisons for improved data sharing.

I believe that I have all the required capabilities and experience to act as a Director of the Metabolomics Society. I, hereby, give my commitment to better serve and promote our community and the Metabolomics Society. Thus, I request you all kindly vote for me.

Back to top